MedCity News April 4, 2024
Katie Adams

Chicago-based Prenosis gained FDA clearance for its sepsis detection technology this week, marking the first time the agency has cleared an AI diagnostic tool for sepsis.

This week, Prenosis gained FDA clearance for its sepsis detection technology — marking the first time the agency has cleared an AI diagnostic tool for sepsis.

Chicago-based Prenosis was founded in 2014 with “a mission to bring precision medicine to acute care,” said CEO and Co-founder Bobby Reddy in an interview.

“We want each patient in the hospital to be treated based on their biology,” he explained. “We realized that, unfortunately, a lot of the technology in hospitals is focused around protocols — meaning that you would treat a patient that is 25 years...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
Related Articles:
FDA Approves First Biosimilar of Xolair
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Share This Article